Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 96

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 96
---
, personnel
or operations of the acquired companies, particularly if the key personnel of the acquired company choose not to work for it, they are
operationally difficult to integrate, or NewGenIvf has difficulty retaining the clients of any acquired business due to changes in ownership,
management or otherwise. These transactions may also disrupt its business, divert its resources, and require significant management attention
that would otherwise be available for development of its existing business and may not benefit NewGenIvf’s business strategy, may
not generate sufficient revenues to offset the associated acquisition costs or may not otherwise result in the intended benefits. Any
such transactions that NewGenIvf is able to complete may not result in any synergies or other benefits it had expected to achieve, which
could result in impairment charges that could be substantial. In addition, NewGenIvf may not be able to find and identify desirable acquisition
targets or business opportunities or be successful in entering into an agreement with any particular strategic partner. These transactions
could also result in dilutive issuances of equity securities or the incurrence of debt, which could adversely affect its results of operations.
In addition, if the resulting business from such a transaction fails to meet NewGenIvf’s expectations, or it fails to successfully
integrate such businesses into its own, its business, financial condition and results of operations may be adversely affected or it may
be exposed to unknown risks or liabilities. Even when NewGenIvf identifies an appropriate acquisition or investment target, it may not
be able to negotiate the terms of the acquisition or investment successfully, obtain financing for the proposed transaction, or integrate
the relevant businesses into its existing business and operations. Strategic investments or acquisitions will involve risks commonly
encountered in business relationships, including:

| ● | difficulties                                                                                                                            
 in assimilating and integrating the operations, personnel, systems, data, technologies, products and services of the acquired business; |

| ● | inability                                                                                                                                  
 of the acquired technologies, products or businesses to achieve expected levels of revenue, profitability, productivity or other benefits; |

| ● | difficulties in retaining,                          
 training, motivating and integrating key personnel; |

| ● | diversion of management’s                                    
 time and resources from NewGenIvf’s normal daily operations; |

| ● | difficulties in maintaining                                                             
 uniform standards, controls, procedures and policies within the combined organizations; |

| ● | difficulties in retaining                                                       
 relationships with customers, employees and suppliers of the acquired business; |

| ● | risks of entering markets                               
 in which